PubMed:27184800 / 0-165 JSONTXT

{"project":"LitCoin-sentences","denotations":[{"id":"T1","span":{"begin":0,"end":116},"obj":"Sentence"},{"id":"T2","span":{"begin":117,"end":128},"obj":"Sentence"}],"text":"Metallothionein-1 as a biomarker of altered redox metabolism in hepatocellular carcinoma cells exposed to sorafenib.\nBACKGROUND: Sorafenib, a kinase inhibitor active"}

{"project":"LitCoin-entities","denotations":[{"id":"11324","span":{"begin":0,"end":17},"obj":"GeneOrGeneProduct"},{"id":"11325","span":{"begin":64,"end":88},"obj":"DiseaseOrPhenotypicFeature"},{"id":"11326","span":{"begin":106,"end":115},"obj":"ChemicalEntity"},{"id":"11327","span":{"begin":129,"end":138},"obj":"ChemicalEntity"}],"attributes":[{"id":"A1","pred":"db_id","subj":"11324","obj":"NCBIGene:4495"},{"id":"A2","pred":"db_id","subj":"11325","obj":"MESH:D006528"},{"id":"A3","pred":"db_id","subj":"11326","obj":"MESH:D000077157"},{"id":"A4","pred":"db_id","subj":"11327","obj":"MESH:D000077157"}],"namespaces":[{"prefix":"_base","uri":"https://w3id.org/biolink/vocab/"},{"prefix":"MESH","uri":"http://id.nlm.nih.gov/mesh/"},{"prefix":"NCBITaxon","uri":"https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id="},{"prefix":"NCBIGene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"OMIM","uri":"https://www.omim.org/entry/"},{"prefix":"DBSNP","uri":"https://www.ncbi.nlm.nih.gov/snp/"}],"text":"Metallothionein-1 as a biomarker of altered redox metabolism in hepatocellular carcinoma cells exposed to sorafenib.\nBACKGROUND: Sorafenib, a kinase inhibitor active"}

{"project":"LitCoin_Mondo","denotations":[{"id":"T1","span":{"begin":64,"end":88},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T2","span":{"begin":79,"end":88},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"0007256"},{"id":"A2","pred":"mondo_id","subj":"T2","obj":"0004993"}],"text":"Metallothionein-1 as a biomarker of altered redox metabolism in hepatocellular carcinoma cells exposed to sorafenib.\nBACKGROUND: Sorafenib, a kinase inhibitor active"}

{"project":"LitCoin-GeneOrGeneProduct-v0","denotations":[{"id":"T1","span":{"begin":0,"end":17},"obj":"GeneOrGeneProduct"},{"id":"T2","span":{"begin":89,"end":94},"obj":"GeneOrGeneProduct"},{"id":"T3","span":{"begin":142,"end":158},"obj":"GeneOrGeneProduct"},{"id":"T4","span":{"begin":159,"end":165},"obj":"GeneOrGeneProduct"}],"text":"Metallothionein-1 as a biomarker of altered redox metabolism in hepatocellular carcinoma cells exposed to sorafenib.\nBACKGROUND: Sorafenib, a kinase inhibitor active"}

{"project":"LitCoin-GeneOrGeneProduct-v2","denotations":[{"id":"T1","span":{"begin":0,"end":17},"obj":"GeneOrGeneProduct"},{"id":"T2","span":{"begin":142,"end":158},"obj":"GeneOrGeneProduct"}],"text":"Metallothionein-1 as a biomarker of altered redox metabolism in hepatocellular carcinoma cells exposed to sorafenib.\nBACKGROUND: Sorafenib, a kinase inhibitor active"}

{"project":"LitCoin-Disease-MeSH","denotations":[{"id":"T1","span":{"begin":64,"end":88},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A1","pred":"originalLabel","subj":"T1","obj":"D006528"}],"text":"Metallothionein-1 as a biomarker of altered redox metabolism in hepatocellular carcinoma cells exposed to sorafenib.\nBACKGROUND: Sorafenib, a kinase inhibitor active"}

{"project":"LitCoin-GeneOrGeneProduct-v3","denotations":[{"id":"T1","span":{"begin":0,"end":17},"obj":"GeneOrGeneProduct"},{"id":"T2","span":{"begin":142,"end":158},"obj":"GeneOrGeneProduct"}],"text":"Metallothionein-1 as a biomarker of altered redox metabolism in hepatocellular carcinoma cells exposed to sorafenib.\nBACKGROUND: Sorafenib, a kinase inhibitor active"}

{"project":"LitCoin_Mondo_095","denotations":[{"id":"T1","span":{"begin":64,"end":88},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"0007256"}],"text":"Metallothionein-1 as a biomarker of altered redox metabolism in hepatocellular carcinoma cells exposed to sorafenib.\nBACKGROUND: Sorafenib, a kinase inhibitor active"}

{"project":"LitCoin-MeSH-Disease-2","denotations":[{"id":"T1","span":{"begin":64,"end":88},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A1","pred":"ID:","subj":"T1","obj":"D006528"}],"text":"Metallothionein-1 as a biomarker of altered redox metabolism in hepatocellular carcinoma cells exposed to sorafenib.\nBACKGROUND: Sorafenib, a kinase inhibitor active"}

{"project":"LitCoin-MONDO_bioort2019","denotations":[{"id":"T1","span":{"begin":64,"end":88},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A1","pred":"#label","subj":"T1","obj":"D006528"}],"text":"Metallothionein-1 as a biomarker of altered redox metabolism in hepatocellular carcinoma cells exposed to sorafenib.\nBACKGROUND: Sorafenib, a kinase inhibitor active"}

{"project":"LitCoin-Chemical-MeSH-CHEBI","denotations":[{"id":"T1","span":{"begin":0,"end":15},"obj":"ChemicalEntity"},{"id":"T2","span":{"begin":106,"end":115},"obj":"ChemicalEntity"},{"id":"T4","span":{"begin":129,"end":138},"obj":"ChemicalEntity"}],"attributes":[{"id":"A1","pred":"ID:","subj":"T1","obj":"ChemicalEntity"},{"id":"A2","pred":"ID:","subj":"T2","obj":"D000077157"},{"id":"A3","pred":"ID:","subj":"T2","obj":"http://purl.obolibrary.org/obo/CHEBI_50924"},{"id":"A4","pred":"ID:","subj":"T4","obj":"D000077157"},{"id":"A5","pred":"ID:","subj":"T4","obj":"http://purl.obolibrary.org/obo/CHEBI_50924"}],"text":"Metallothionein-1 as a biomarker of altered redox metabolism in hepatocellular carcinoma cells exposed to sorafenib.\nBACKGROUND: Sorafenib, a kinase inhibitor active"}

{"project":"LitCoin-training-merged","denotations":[{"id":"T4","span":{"begin":129,"end":138},"obj":"ChemicalEntity"},{"id":"T2","span":{"begin":106,"end":115},"obj":"ChemicalEntity"},{"id":"T91597","span":{"begin":0,"end":15},"obj":"ChemicalEntity"},{"id":"T54816","span":{"begin":142,"end":158},"obj":"GeneOrGeneProduct"},{"id":"T81538","span":{"begin":0,"end":17},"obj":"GeneOrGeneProduct"},{"id":"T28839","span":{"begin":64,"end":88},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A5","pred":"ID:","subj":"T4","obj":"http://purl.obolibrary.org/obo/CHEBI_50924"},{"id":"A4","pred":"ID:","subj":"T4","obj":"D000077157"},{"id":"A3","pred":"ID:","subj":"T2","obj":"http://purl.obolibrary.org/obo/CHEBI_50924"},{"id":"A2","pred":"ID:","subj":"T2","obj":"D000077157"},{"id":"A38342","pred":"ID:","subj":"T91597","obj":"ChemicalEntity"},{"id":"A5937","pred":"#label","subj":"T28839","obj":"D006528"}],"text":"Metallothionein-1 as a biomarker of altered redox metabolism in hepatocellular carcinoma cells exposed to sorafenib.\nBACKGROUND: Sorafenib, a kinase inhibitor active"}